Results 81 to 90 of about 40,172 (184)

Ultrafiltration of the Virus of Vesicular Stomatitis

Experimental Biology and Medicine, 1935
SummaryThe filtration end-point of the virus of vesicular stomatitis, or the average pore diameter of the finest membrane passing the virus, was found to be approximately 140 mμ. Two im-munologically distinct strains of the virus, the “Indiana” and the “New Jersey” maintained either in tissue culture or in mouse brain, were studied, and the filtration ...
J. H. Bauer, H. E. Cox
openaire   +1 more source

Acute malaria dysregulates specialized lymph node macrophages to suppress vaccine-elicited protection against the Ebola virus

mBio
The filovirus, Ebola virus (EBOV), causes outbreaks of EBOV disease (EVD) throughout equatorial Africa. ERVEBO is a replication-competent recombinant vesicular stomatitis virus-vectored vaccine encoding the EBOV glycoprotein (recombinant vesicular ...
Jonah Elliff, Lindsey Grady, Kyle L. O'Donnell, Caitlin Messingham, Kai J. Rogers, Jobaida Akther, Andrew Thurman, Rahul Vijay, Alejandro Pezzulo, Troy Randall, Andrea Marzi, Noah S. Butler, Wendy Maury   +12 more
doaj   +1 more source

Vesicular Stomatitis Virus Transmission: A Comparison of Incriminated Vectors

Insects, 2018
Vesicular stomatitis (VS) is a viral disease of veterinary importance, enzootic in tropical and subtropical regions of the Americas. In the U.S., VS produces devastating economic losses, particularly in the southwestern states where the outbreaks display
Paula Rozo-Lopez, Barbara S. Drolet, Berlin Londoño-Renteria   +2 more
doaj   +1 more source

Comparative inactivation of Aujeszky's disease virus, Porcine teschovirus and Vesicular stomatitis I by chemical disinfectants

Veterinární Medicína, 2008
We tested the germicide activity of 1% Chloramin BM, 1% Incidin Plus, 1% Lysoformin 3000, 0.2% Mikasept KP, and 2% Sekusept Forte against viruses in suspension (suspension test) and dried onto a surface (carrier test).
H. Dvorakova, J. Prodelalova, M. Reichelova   +2 more
doaj   +1 more source

Vesicular stomatitis virus [PDF]

Cancer Cell, 2003
Giedlin, Martin A, Cook, David N, Dubensky Jr., Thomas W   +2 more
openaire   +1 more source

DIRECTED EVOLUTION OF AN ONCOLYTIC VESICULAR STOMATITIS VIRUS ADAPTED TO HUMAN MALIGNANT MENINGIOMA CELLS

Sabiad
Objectives: Recombinantly-engineered versions of the oncolytic virus VSV are currently under clinical investigation for the treatment of several different types of cancer.
Burak Gizem Göleş, Hülya Yazıcı, John N. Davis   +2 more
doaj   +1 more source

VSV-CHIKV activates antitumor immunity by inducing pyroptosis in a melanoma model

Discover Oncology
Melanoma is the most dangerous skin cancer due to its difficulty in treatment, high recurrence rate and metastatic ability. As a vector for oncolytic viruses (OVs), vesicular stomatitis virus (VSV) has been shown to be effective against malignant ...
Fan Wu, Ying Zhan, Siyu Wang, Xiaoke Wang, Min Hui, Jian Zhang, Jing Zhang, Hongxu Yang, Yingfeng Lei, Shibin Yu   +9 more
doaj   +1 more source

Ginsenoside Rh1 Suppresses Vesicular Stomatitis Virus Replication by Inhibiting Autophagy to Promote Immune Responses. [PDF]

Microorganisms
Chen H, Zhao Q, Wei D, Hu Z, Zhu X, Zhang R.   +5 more
europepmc   +1 more source

Swine TRIM25 inhibits vesicular stomatitis virus replication by activation of type I IFN signaling pathway and binding vRNA. [PDF]

J Vet Sci
Cao Y, Zhang J, Yoo D, Zhang H, Jiang D, Hu Y, Cong X, Li J, Wu X, Du Y, Qi J, Huang J.   +11 more
europepmc   +1 more source

Low-density lipoproteins in human serum competitively inhibit the binding and entry of vesicular stomatitis virus. [PDF]

Mol Ther Adv
Vandergaast R, Johnson S, Ziegler C, Nenavath GN, Schnebeck L, Narjari R, Russell SJ.   +6 more
europepmc   +1 more source